High Intensity Focused Ultrasound (HIFU) technology
HIFU treatment cures localized prostate cancer by focusing high intensity ultrasound on a defined area into the prostate. The concentration of ultrasounds turns up the temperature at the focal point until the gland’s cells are destroyed with no damage of the surrounding tissues. The action is similar to the sun’s rays passing through a magnifying glass triggering a burn at the focal point. HIFU treatment is non-invasive (incisionless and radiation free). It has been used in humans since 1993 and has demonstrated its therapeutic efficacy. Treatment of localized prostate cancer by HIFU is recognized by urological medical associations from several countries.
Focal One® is indicated for the treatment of localized prostate cancer. Focal One® is intended for the destruction of a localized adenocarcinoma of the prostate gland by high intensity focused rectal ultrasound. Manufactured by EDAP TMS France, Focal One® is a class IIb regulated medical device which carries the CE mark under these regulations. Its conformity assessment was carried out by G-MED (0459). It is imperative that you refer to your urologist.